Cargando…
Efficacy and safety of PLDR‐IMRT for the re‐irradiation of recurrent NPC: A prospective, single‐arm, multicenter trial
Salvage treatment of locoregionally recurrent nasopharyngeal carcinoma (NPC) requires weighing the benefits of re‐irradiation against increased risks of toxicity. Here, we evaluated the outcomes of patients treated with intensity‐modulated‐based pulsed low‐dose‐rate radiotherapy (PLDR‐IMRT) to enhan...
Autores principales: | Huang, Rui, Li, Zhihui, Yang, Fan, Zhang, Yu, Jiang, Yanhui, Li, Churong, Gao, Hui, Li, Guanghui, Liu, Yimin, Guo, Wenyan, Yang, Dingqiang, Zhang, Shichuan, Li, Jie, Wen, Hao, Lang, Jinyi, Zhang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236609/ https://www.ncbi.nlm.nih.gov/pubmed/36788727 http://dx.doi.org/10.1111/cas.15759 |
Ejemplares similares
-
NACT+IMRT versus NACT+IMRT+CCRT in locoregionally advanced NPC patients: a retrospective study
por: Chen, Xialin, et al.
Publicado: (2019) -
Optimizing the Region for Evaluation of Global Gamma Analysis for Nasopharyngeal Cancer (NPC) Pretreatment IMRT QA by COMPASS: A Retrospective Study
por: Lu, Wenli, et al.
Publicado: (2022) -
Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT
por: Xiang, Geng, et al.
Publicado: (2023) -
Re-irradiation of spinal column metastases by IMRT: impact of setup errors on the dose distribution
por: Gröger, Christian, et al.
Publicado: (2013) -
Dose Escalation of Lobaplatin Concurrent with IMRT for the Treatment of Stage III-IVb NPC: A Phase I Clinical Trial()()
por: Wang, Si-Yang, et al.
Publicado: (2018)